guidelines. This included item generation from a systematic review of existing tools and expert opinion on task difficulty and relevance, involving individuals with DMD. Cultural aspects affecting ADL were taken into consideration to make this tool applicable to the broad DMD community. Items were selected in relation to a conceptual framework reflecting disease progression covering the full range of upper limb function across different ADL domains.
The emergence of new therapeutic strategies for Duchenne muscular dystrophy (DMD) has exposed the need for suitable outcome measures to assess their efficacy within the framework of clinical trials. So far, the focus of trials has been put on the ambulant stage of the disease. Extensive research has been done on the clinical feasibility and psychometric properties of the 6-minute walk test, North Star Ambulatory Assessment, and the timed function tests. [1] [2] [3] However, with longer trials and post-marketing requirements there is a need for outcome measures encompassing different stages of the disease.
The next step therefore is to invest in developing outcome measures that describe disease progression in the upper limbs from early ambulant stages over transition stages to non-ambulant stages. These would allow a better understanding of disease evolution and efficacy of interventions throughout the lifespan.
Upper limb weakness manifests when male children are still ambulant and is seen first in the proximal muscles. 4, 5 Further progression of weakness is evident in a proximal to distal gradient, and upper limb function becomes increasingly influenced by weakness in conjunction with contractures and/or growth, resulting in compensatory strategies and ultimately loss of function. In the end stage, movements are limited to the fingers. Muscle weakness affects activities of upper limb function and performance of activities of daily living (ADL). The relationship between muscle strength and function is not linear but influenced by compensatory behaviour, personal (such as age, lifestyle, motivation) and environmental factors. Therefore, the assessment of limitations in upper limb function in daily life warrants further investigation.
A multidisciplinary international clinical outcome group highlighted the lack of suitable outcome measures within this context, 6 and as a first step they developed the Performance of the Upper Limb module (PUL), a performance outcome measure specifically designed for upper limb function in patients with DMD. 7 Reliability and responsiveness to change for this tool have been published. 8 In addition to the PUL, this group also identified the need to develop in parallel a patient-reported outcome measure (PROM) to complement information on ADL that cannot otherwise be observed in a clinical or research setting (e.g. feeding, washing, and leisure activities) and focusing on outcomes that are clinically meaningful in the patients' daily life and that may impact on their quality of life.
Therefore, the aim was to develop a PROM on upper limb function in ADL specifically for patients with DMD across a wide age range and applicable in the different stages of the disease. Such an instrument could provide a measure of the patients' level of independence and ability to interact with the environment. The main purpose of the DMD Upper Limb PROM is for use in describing natural history in DMD and in assessing the efficacy of interventions in daily life.
METHOD Questionnaire development
The development of the DMD Upper Limb PROM was based on PROM guidelines published by the US Food and Drug Administration, 9 and followed several steps (Fig. 1 ). Five face-to-face meetings were held in Rome (Italy), Leuven (Belgium), and Amsterdam (the Netherlands) between 2012 and 2015, organized by the Duchenne Parent Project. Focus groups involved medical doctors, researchers, physiotherapists, and clinicians working with patients with DMD as well as representatives from patients, advocacy groups, and industries.
Development of a conceptual framework
The concept to be measured was defined as upper limb function within the activity domain of the International Classification of Functioning, Disability and Health. In relation to the PUL, 7 the questionnaire should reflect the progression of weakness and the natural history of functional decline in daily life of those with DMD. Items should be selected to cover the widest range of upper limb activities in daily life from unimanual to bimanual activities and dexterity.
Systematic and critical review of existing questionnaires
A systematic review was performed to identify existing questionnaires used in DMD assessing aspects related to upper limb function in daily life. Five questionnaires were identified: the Egen Klassifikation, 10 the ACTIVLIM, 11 the ABILHAND, 12 the Muscular Dystrophy Functional Rating Scale, 13 and the Duchenne muscular dystrophy Functional Ability Self-Assessment Tool.
14 All these questionnaires assessed a wide range of abilities whereas the ABILHAND has specifically been developed for assessing manual abilities. Details of the results of this review have been reported. 15 However, none of these questionnaires covers the whole spectrum of abilities found in ambulant and non-ambulant male children and young males with DMD. Therefore, all items were submitted to the multidisciplinary international clinical outcome group with the aim of determining their clinical meaningfulness for the target group, as well as proposing other relevant items not included in the original item set.
Selection and adaptation of items
On the basis of clinical relevance and potential to measure upper limb function in daily life, items were selected by the working group. Individuals with DMD were involved throughout the iterative process by offering their opinion on task difficulty and relevance. Cultural aspects were also taken into consideration to make this tool applicable to a broad, international DMD community. Items were selected in relation to the different domains of the PUL, from antigravity shoulder movements to limited finger movements, in order to cover the full range of upper limb function. Items were further refined, added, or eliminated on the basis of feedback from the multidisciplinary group and individuals with DMD. The scoring was also critically reviewed and adapted to reflect disease progression and reduce possible floor and ceiling effects. A pilot pro forma was developed and tested in an international multi-centric setting. The pro forma included 39 items categorized in four domains of daily life: food, self-care, household and environment, leisure and communication.
The DMD Upper Limb PROM was officially translated into French, Dutch, German, Italian, Portuguese, Spanish, Turkish, Danish, and Swedish. This process involved translation by official translators, which was corrected afterwards by a native-speaking expert working in the field of neuromuscular disorders, followed by backward translation to guarantee the accuracy of the translation. The questionnaires were self-completed by the children when possible, or by their parents or caregivers.
Analysis review Rasch model
The Rasch model estimates the item difficulty and a participant's ability on a common linear scale based on the responses provided for each item. The model assumes that participants with a higher ability level have a higher probability of positively responding to an item compared with What this paper adds
• A new patient-reported outcome measure (PROM) for Duchenne muscular dystrophy (DMD) has been developed.
• The DMD Upper Limb PROM targets upper limb function in daily life.
• Psychometric techniques confirmed its unidimensionality, internal consistency, and test-retest reliability.
• Involvement of different stakeholders guaranteed the clinical relevance of the tool.
participants with a lower ability. Every participant's ability and each item difficulty are represented by a score, expressed in logits (log odds units), a linear unit defined as the natural logarithm of the odds of positive achievement of any item by a participant. The Rasch analysis was computed with RUMM 2030 version 5.1 for Windows (http:// www.rummlab.com.au/; RUMM Laboratory, Perth, Australia). This program provides fit statistics that express the extent to which each item contributes to a single dimension (upper limb function in daily life). Included are overall fit statistics (item trait interaction and person separation index), and fit statistics for individual items and persons. The item-trait interaction (a v 2 value) reflects the degree of invariance across the aimed dimension. A probability exceeding 0.05 indicates that the data fit the model. The person separation index is an estimate of the internal consistency reliability and is similar to Cronbach's a. The individual item-fit and person-fit statistics are represented by their item locations (in logits), standard errors, residuals, and fit to the model. The residual values express a source of misfit to the model, and are defined as being greater than SD 2.5. [16] [17] [18] For test-retest reliability, 15 children with DMD of one centre (Leuven) or their caregivers completed the questionnaire twice with a time interval between 7 days and 14 days. This interval was chosen as it was long enough not to remember the responses, but short enough to avoid actual changes in the ability level owing to the progression of the disease. The intraclass correlation coefficient (2.1) was calculated.
Discriminative ability of the DMD Upper Limb PROM, which would confirm construct validity, was examined by Development of a conceptual framework reflecting the disease progression and functional decline in DMD with input from a broad array of stakeholders Systematic and critical review of the existing questionnaires that include items related to upper limb function Selection and adaptation of existing items and integration of newly constructed items based on input from experts, patients, and families Involvement of male children and adults with DMD and their families in an iterative process to establish the clinical meaningfulness and relevance of items to activities of daily living and validate the conceptual framework Development of a pilot pro forma with a first selection of items suitable for ambulant and non-ambulant young males with DMD Application of the questionnaire in a multi-centre setting and consecutive Rasch analyses Discussion with experts, patients, and families to interpret the results of the Rasch analyses followed by adaptations of the questionnaire Development of the final questionnaire testing the differences in total scores between the different Brooke levels 19 with one-way analysis of variance (ANOVA) and post hoc Bonferroni t-tests, using SAS Enterprise Guide (http://support.sas.com/software/products/guide/; SAS Institute, Cary, NC, USA).
Participants
Participants were recruited between 2013 and 2015 through eight international specialized centres (Rome, Italy; London, UK; Leuven, Belgium; Messina, Italy; Newcastle, UK; Paris, France; Nijmegen, the Netherlands; Aarhus, Denmark). Individuals were eligible if they were male, had a diagnosis of DMD, and were aged 7 years or older. All patients or their parents gave informed consent for participation.
RESULTS
The first experimental version of the DMD Upper Limb PROM included 39 items. For each question, the participants and their parents were asked to fill in their perceived difficulty to perform the activity on a four-level ordinal scale: 'cannot do'; 'very hard'; 'a little hard'; 'easy'. A Rasch analysis was performed on the results of 101 assessments (mean age 12y, standard deviation [SD] 4; ambulant n=52, non-ambulant n=49). In response to this primary analysis, six items were deleted because of issues with item fit, disordered thresholds, dependency, and targeting (ceiling effect).
The second experimental version included 33 items and four response categories: cannot do; very hard; a little hard; easy. A second Rasch analysis was performed in 357 assessments (mean age 12y, SD 4; ambulant n=198, nonambulant n=159). In response to this second analysis, one item was deleted ('use touch pad') because of redundancy, and the number of response categories was reduced from four to three because of disordered thresholds. Feedback from patient groups and clinicians suggested that a lack of distinction between the categories of 'very hard' and 'a little hard' could be a reason for lack of ordered thresholds for many of the items.
The final questionnaire consisted of 32 items covering four domains of ADL: (1) food, seven items; (2) self-care, eight items; (3) household and environment, six items; (4) leisure and communication, 11 items. For each question, the participants and their parents were asked to fill in their perceived difficulty in performing the activity on a threelevel scale: cannot do; can do with difficulty; can do easily. The time to administer the PROM never exceeded 10 minutes. We recommend using the questionnaire in participants from 7 years of age, and having it completed by parents or caregivers up to the age of 16 years.
A total of 194 participants with DMD recruited across eight international specialized centres for DMD completed the third and final version of the DMD Upper Limb PROM. Their mean age was 15 years (SD 7y, range 7-43y). Eighty-four individuals (43%) were ambulant and 128 (66%) were on steroids. The questionnaire was completed by caregivers for 130 participants (67%), and 64 participants (23%) independently completed the questionnaire. The fit of individual responses was adequate (person's mean fit residual À0.35, SD 0.68). Participants were evenly distributed across ability levels (Fig. 2) . The range of the upper histogram horizontally extending outside the range of the lower histogram suggests acceptable floor and ceiling levels (in 11 and five children respectively). The item response option thresholds were ordered for 30 out of 32 items, indicating that the proposed scoring system worked as intended for most items (Fig. 3) . Disordered thresholds were found in two items ('pick up pen from floor' and 'pull up trousers'), indicating that participants had difficulty discriminating between response categories given their functional ability. Category probability curves showed that in these two items the category 'with difficulty' did not emerge as the most likely to be selected at any point upon the underlying scale, meaning that the perception of these items is more binary in nature, and that these activities are perceived as either impossible, or easy, with very rare intermediate responses.
The overall item-trait interaction v 2 value was 174.33 (64 degrees of freedom; p<0.001). Unidimensionality was acceptable (t-test 9.2%, binomial test lower 95% confidence interval proportion 0.05). The person separation index was estimated at 0.97, indicating very high reliability.
Only two items ('press elevator buttons' and 'turn on a light switch') displayed a positive correlation above 0.40 (r=0.41). These items would be expected to show that even though the tasks are different they require a similar level of ability to perform. This dependency could artificially inflate reliability as measured by the person separation index. However, removing the items from analysis did not significantly alter this index (person separation index 0.97). As they are both important from a clinical point of view, it was decided to keep both items in the questionnaire.
For discriminant ability, significant differences were found between the Brooke levels (F=248.15; p<0.001). Figure 4 shows decreasing total DMD Upper Limb PROM scores (expressed as percentages) with increasing Brooke levels. Post hoc comparisons yielded significant differences between the levels, except for comparisons between adjacent levels 1 to 2, 3 to 4, and 5 to 6.
Test-retest reliability
An intraclass correlation coefficient of 0.99 showed excellent agreement between the first and second assessment.
DISCUSSION
The aim of this study was to develop a DMD-specific PROM and to evaluate its ability to measure the underlying construct of upper limb function in daily life in male children and young males with DMD. The clinical relevance of the questionnaire was guaranteed by involving all stakeholders, including the patient community. Its internal reliability and validity has been demonstrated on the basis of modern psychometric methods in a large set of patients from eight different centres.
New developments in therapy for DMD have highlighted the need for disease-specific instruments that assess activity limitations in the context of clinical trials. An extensive literature search identified a gap in suitable outcome measures for assessing upper limb function in DMD across all stages of the disease. 15 A multidisciplinary international clinical outcome group consisting of clinicians, scientists, industries, young males with DMD, and patient advocacy groups developed an observer-rated tool, specifically designed for assessing upper limb function in ambulant and non-ambulant DMD (PUL). 7 However, there was still a need to better understand patient and caregiver perception of abilities related to upper limb function in daily life, which cannot otherwise be observed in a clinical or research setting, for example feeding, washing, and leisure activities. 
Brooke 2 n=26
Brooke 3 n=33
Brooke 4 n=7
Brooke 5 n=43 The final 32 items in this questionnaire cover four domains of ADL (food, self-care, household and environment, leisure and communication). They were selected on the basis of clinical relevance and iterative Rasch analyses, and they showed a good fit, with nearly all the response categories working appropriately. The simplified scoring of four to three categories contributed to this improvement. These findings suggest that this scale is suitable for assessing perception of upper limb function in daily life in this population. Testing of the first and second experimental version included only a few adult patients; to investigate the possible floor effect, the age range was extended in the final testing. The targeting of the scale showed minimal issues with floor and ceiling effects; however, these issues may well be part of the population's natural course as there is a point when upper limb function is fully preserved in either weaker ambulant children or in stronger non-ambulant children. Also, adult males in the later stages of the disease may reach a point where they have no useful upper limb function because of progressive contractures and muscle weakness. Eleven patients aged between 23 years and 34 years old with Brooke levels 5 or 6 had the minimum score on the DMD Upper Limb PROM. These adults were in such an advanced disease stage that they either had no upper limb function left (Brooke level 6) or only had the ability to drive their electric wheelchair with joystick control that required minimal hand movement (Brooke level 5).
Brooke 6 n=12
The strengths of this questionnaire compared with other existing scales assessing activities in daily life are that (1) it focuses on upper limb function in daily life (unidimensional) and (2) it is DMD-specific, covering the whole spectrum of disease evolution.
This questionnaire has been developed for young males/ children with DMD from the age of 7 years, an age at which a maximum score on the PROM may be obtained in typically developing children. We recommend having it completed by parents or caregivers up to the age of 16 years, because previous publications have indicated that parents more accurately discriminate function in a Likerttype rating scale than children, who tend to perceive activities in a dichotomous way ('impossible' or 'easy'). 20 However, inherent in questionnaires completed by parents or caregivers is the 'proxy effect', which means inaccurate reporting about characteristics of others, which poses a threat to the validity of information. 21 Therefore, we recommend asking the individual to self-report the questionnaire from the age of 17 years.
We acknowledge several limitations in our study. First, our data set was formed from cross-sectional data. Despite the fact that our data provided a sufficient sample, longitudinal data analysis is needed to assess stability of the scale over time and its sensitivity to capture disease progression in a population where change appears to occur over a long period. Second, this study was unable to assess construct validity given that no criterion standard in functional assessment for this population exists. Nevertheless, the development of a conceptual framework reflecting expert opinion on disease progression in upper limb function in DMD supports the construct to be measured by this questionnaire. Finally, an inherent challenge in developing an internationally sensitive PROM assessing function is the inability to control for external impact factors such as socioeconomic and cultural aspects, as well as environmental adaptations that would intervene with the answers of the respondents. Therefore, experts from different centres in Europe and the USA were involved to ensure large applicability of this scale independent of cultural and environmental factors. Further consideration for Africa and Asia should be taken in the next steps.
In conclusion, this collaborative effort resulted in the creation of the DMD Upper Limb PROM. Applied modern psychometric methods and specialist clinical knowledge, patient, and family feedback has ensured that the DMD Upper Limb PROM is not only disease-and population-specific but also assesses clinically meaningful upper limb function in this population. The main purpose of this questionnaire is to describe patient self-reported natural history in DMD and to assess the efficacy of interventions in daily life. Although the metric properties allow capture of changes in upper limb function in daily life over time and after intervention, further study is warranted on the responsiveness and predictiveness of the DMD Upper Limb PROM.
